PRLD - Prelude Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PRLD is currently covered by 3 analysts with an average price target of $1.88. This is a potential upside of $0.63 (50.4%) from yesterday's end of day stock price of $1.25.

Prelude Therapeutics 's activity chart (see below) currently has 25 price targets and 32 ratings on display. The stock rating distribution of PRLD is 42.86% BUY, 50% HOLD and 7.14% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.07% with an average time for these price targets to be met of 81.5 days.

Highest price target for PRLD is $5, Lowest price target is $3, average price target is $1.88.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 08-Nov-2024. First documented stock forecast 20-Oct-2020.

Best performing analysts who are covering PRLD - Prelude Therapeutics :

Tazeen Ahmad Robert Burns Jeffrey Hung Peter Lawson

Currently out of the existing stock ratings of PRLD, 6 are a BUY (42.86%), 7 are a HOLD (50%), 1 are a SELL (7.14%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5

$3.66 (273.13%)

$5

1 months 25 days ago
(08-Nov-2024)

5/14 (35.71%)

$3.8 (316.67%)

100

Hold

$3

$1.66 (123.88%)

$5

6 months 13 days ago
(20-Jun-2024)

2/5 (40%)

$-0.71 (-19.14%)

168

Sell

$4

$2.66 (198.51%)

$10

1 years 14 days ago
(19-Dec-2023)

2/7 (28.57%)

$-0.04 (-0.99%)

4

Hold

$6

$4.66 (347.76%)

$10

2 years 1 months 12 days ago
(21-Nov-2022)

3/5 (60%)

$-0.53 (-8.12%)

54

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRLD (Prelude Therapeutics ) average time for price targets to be met?

On average it took 81.5 days on average for the stock forecasts to be realized with a an average price target met ratio 41.07

Which analyst has the current highest performing score on PRLD (Prelude Therapeutics ) with a proven track record?

TAZEEN AHMAD

Which analyst has the current lower performing score on PRLD (Prelude Therapeutics ) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on PRLD (Prelude Therapeutics )?

Tazeen Ahmad works at BAML and has 5 price targets and 3 ratings on PRLD

Which analyst is the currently most bullish on PRLD (Prelude Therapeutics )?

Tazeen Ahmad with highest potential upside - $4.66

Which analyst is the currently most reserved on PRLD (Prelude Therapeutics )?

Peter Lawson with lowest potential downside - $1.66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?